PINNACLE PCL Trademark
Trademark Overview
On Monday, February 28, 2022, a trademark application was filed for PINNACLE PCL with the United States Patent and Trademark Office. The USPTO has given the PINNACLE PCL trademark a serial number of 97287810. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The PINNACLE PCL trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, respiratory, and hematologic diseases and disorders; medical information services in the nature of providing a database in the field of gene therapy information based on collected patient data and information all for treatment and diagnostic purposes; medical information services
General Information
| Serial Number | 97287810 |
| Word Mark | PINNACLE PCL |
| Filing Date | Monday, February 28, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, June 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 23, 2023 |
Trademark Statements
| Goods and Services | Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, respiratory, and hematologic diseases and disorders; medical information services in the nature of providing a database in the field of gene therapy information based on collected patient data and information all for treatment and diagnostic purposes; medical information services |
| NOT AVAILABLE | "PCL" |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 3, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 3, 2022 | NEW APPLICATION ENTERED |
| Thursday, March 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 12, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, December 14, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 14, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 14, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, March 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 3, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 23, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 23, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 18, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, December 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 20, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, December 20, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, December 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 13, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 13, 2024 | SOU EXTENSION 2 FILED |
| Thursday, June 13, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, August 2, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, August 2, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, August 2, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, August 2, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 12, 2024 | SOU TEAS EXTENSION RECEIVED |
